The Vaccine Research Center is a clinical research unit operating within the Faculty of Medicine and Health Technology at the Tampere University in Finland. It carries out clinical trials on vaccines in co-operation with the pharmaceutical industry.
Our mission is to introduce new, safer and more efficient vaccines for both children and adults. We aim to enhance the quality of life by preventing diseases by vaccination. Vaccine Research Center is led by professor of peadiatrics and experimental immunology Mika Rämet M.D., Ph.D., Faculty of Medicine and Health Technology.
Vaccine trials have been carried out at the University of Tampere since 1979, and in accordance with Good Clinical Practice (GCP) since 1991.
Our competent, experienced and dedicated personnel guarantee that the research data we produce are of the highest quality. The trials in Finland are approved by the Finnish Medicines Agency (Fimea), and the National Committee on Medical Research Ethics (TUKIJA) or the local Ethics Committee.
The Center currently operates a network of ten regional vaccine research clinics whose staff include professional study nurses, medical laboratory technologists and investigators. The network of clinics enables the Center to carry out extensive nation-wide trials and to offer a robust contribution to large multinational studies. Leading international vaccine manufacturers have a high opinion of the Center as a partner.
The original specialty of the Center is viral vaccines for children, and the Center is well known for its studies on rotavirus, varicella and influenza vaccines. Studies conducted in Tampere have been pivotal to the registration of rotavirus vaccines globally and the varicella vaccine and MMR + varicella vaccine in Europe. More recent trials on pneumococcal and meningococcal conjugate vaccines have played a key role in the introduction of these vaccines.
The Center also investigates vaccines for adults and the elderly, including hepatitis B vaccines, influenza vaccines and herpes zoster vaccines.